The article reports that Representative Mary Miller (R-IL) is introducing a bill called the “Restoring Safeguards for Risky Abortion drugs Act,” which aims to tighten regulations on the abortion pill Mifepristone. The proposed legislation would require in-person doctor visits to obtain the drug, effectively banning its delivery by mail. This move is intended to reverse the FDA’s previous easing of restrictions that allowed teleprescribing and mailing of the pill, which is used in nearly two-thirds of U.S. abortions.<\/p>\n

The bill, supported by several Republican lawmakers and paired with similar legislation by Senator Josh Hawley (R-MO), seeks to reinstate prescription and safety checkups to address concerns about the drug’s safety.House Republicans argue that chemical abortion drugs<\/a> pose health risks to women, citing a recent conservative study claiming a higher rate of adverse effects, though abortion-rights advocates<\/a> dispute this as unreliable.<\/p>\n

The legislation would also permit lawsuits against individuals, telehealth providers, and pharmacies that mail the abortion pill, and ban foreign companies from importing it. This proposal comes amidst ongoing debates and legal battles over abortion access following the 2022 Supreme court decision overturning Roe v. Wade, with some states enacting telemedicine protections and others imposing strict abortion drug restrictions<\/a>.

\n<\/p>\n